نتایج جستجو برای: kidney cancer

تعداد نتایج: 1115937  

F. Xu, L. Liang, S. Bai, X. Li , Y. Shen, Y. Zhao,

Background: This study evaluated whether IMRT using fewer beams and segments could reduce delivery time without compromising plan quality in gastric cancer adjuvant radiotherapy. Materials and Methods: Fifteen patients with advanced gastric cancer who underwent D2, R0 surgery were included in this study. IMRT plans for each patient were designed as 7 equal beams with 40 segments, 5 beams with 2...

Journal: :Genome research 2012
W Marston Linehan

Kidney cancer is not a single disease; it is made up of a number of different types of cancer, including clear cell, type 1 papillary, type 2 papillary, chromophobe, TFE3, TFEB, and oncocytoma. Sporadic, nonfamilial kidney cancer includes clear cell kidney cancer (75%), type 1 papillary kidney cancer (10%), papillary type 2 kidney cancer (including collecting duct and medullary RCC) (5%), the m...

Journal: :Annals of the Academy of Medicine, Singapore 2013
Shih Wei Lai Kuan Fu Liao Hsueh Chou Lai Pang Yao Tsai Fung Chang Sung Pei Chun Chen

INTRODUCTION The purpose of this study was to explore whether diabetes mellitus (DM) correlates with the risk of kidney cancer in Taiwan. MATERIALS AND METHODS We designed a population-based case-control study from the Taiwan National Health Insurance Database, which consisted of 116 patients with newly diagnosed kidney cancer as cases and 464 subjects without kidney cancer as controls in 200...

Journal: :Journal of the National Comprehensive Cancer Network 2009

2017
Takatsugu Okegawa Megumi Morimoto Satoru Nishizawa Satoshi Kitazawa Kohei Honda Hideo Araki Toshiya Tamura Ayumi Ando Yoshinori Satomi Kikuo Nutahara Takahito Hara

Metabolic alteration constitutes a hallmark of cancer. Glycolysis and antioxidant pathways in kidney cancer are elevated, with frequent mutation of the VHL gene. Intratumor genetic heterogeneity has been recently demonstrated in kidney cancer. However, intratumor metabolic heterogeneity has not been investigated. Here, we used global metabolomics analysis and tissue slice tracer studies to demo...

Journal: : 2022

Based on the results of registration studies, drug cabozantinib, mechanism action which is determined by inhibition tyrosine kinases a relatively wide range cellular receptors, registered in treatment hepatocellular cancer, kidney cancer and thyroid cancer. This literature review collects data action, preclinical experiments phases I–III studies. Emphasis placed tolerability efficacy population...

2018
Hisashi Hasumi Masahiro Yao

Although hereditary kidney cancer syndrome accounts for approximately five percent of all kidney cancers, the mechanistic insight into tumor development in these rare conditions has provided the foundation for the development of molecular targeting agents currently used for sporadic kidney cancer. In the late 1980s, the comprehensive study for hereditary kidney cancer syndrome was launched in t...

2017
MARYAM MOHAMMADIAN REZA PAKZAD FARHAD TOWHIDI BEHNAM REZA MAKHSOSI ABBAS AHMADI HAMID SALEHINIYA

BACKGROUND AND AIMS Kidney cancer is among the cancers that have the highest growth rate in all age and racial groups in the world and is as the most deadly type of urinary tract cancer. Since awareness about this cancer incidence status and mortality is essential for better planning, this study aimed to investigate the incidence and mortality rate of kidney cancer and its relationship with the...

Journal: :International Journal of Health Sciences (IJHS) 2022

Kidney cancer is a disease in which kidney cells become malignant and grow uncontrollably, forming mass or tumor. Before discussing further cancer, it important to briefly know the kidneys. The kidneys are two bean-shaped organs located lower abdomen on left right of spine. primary function excrete water, salt, other unnecessary substances turn them into urine. urine collects renal pelvis (the ...

2017
Masakazu Washio Mitsuru Mori

Background: The incidence of kidney cancer is high in Western Europe, Northern Europe and North America, while it is low in Asia. Although the incidence of kidney cancer in Japan is lower than the rates in the other industrialized countries, there is no doubt that it is increasing. In this paper, we would like to introduce the result of epidemiological studies, which evaluate the nongenetic ris...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید